Skip to main content

Carolina Campos Martinez

Predoctoral Researcher at the Liver Diseases - Viral Hepatitis Research group. Bachelor's degree in Biotechnology and MSc in Translational Biomedical Research by the Vall d'Hebron Institute of Research Fundation. Currently working as a PhD Student at the Liver diseases-Viral hepatitis research group and studying at the PhD program of Biochemistry, Molecular Biology and Biomedicine of Universitat Autònoma de Barcelona. My studies are focused on the evolution of viral quasispecies of SARS-CoV-2 in the most prevalent variants in Barcelona city over the pandemics, thanks to next generation sequencing (MiSeq and Nextseq2000 Illumina platforms), and how these viral quasispecies are involved with clinical and epidemiological purposes.

Institutions of which they are part

Predoctoral researcher
Liver Diseases
Vall Hebron Institut de Recerca

Carolina Campos Martinez

Institutions of which they are part

Predoctoral researcher
Liver Diseases
Vall Hebron Institut de Recerca

Predoctoral Researcher at the Liver Diseases - Viral Hepatitis Research group. Bachelor's degree in Biotechnology and MSc in Translational Biomedical Research by the Vall d'Hebron Institute of Research Fundation. Currently working as a PhD Student at the Liver diseases-Viral hepatitis research group and studying at the PhD program of Biochemistry, Molecular Biology and Biomedicine of Universitat Autònoma de Barcelona. My studies are focused on the evolution of viral quasispecies of SARS-CoV-2 in the most prevalent variants in Barcelona city over the pandemics, thanks to next generation sequencing (MiSeq and Nextseq2000 Illumina platforms), and how these viral quasispecies are involved with clinical and epidemiological purposes.

I studied a Biotechnology degree at the Rovira i Virgili University in Tarragona, Spain. I followed my training during an internship at the Liver Diseases - Viral Hepatitis from VHIR, leaded by Dr. Josep Quer. Finally, I did the TFG in collaboration with Dr. Quer's group which was named "Características genéticas y variabilidad del SARS-CoV-2, agente causal de la COVID-19"

Afterwards, I studied the Traslational Biomedical Research Master by the VHIR and the Universitat Autònoma de Barcelona (UAB), where I worked as liscenced technician at the Liver Diseases - Viral Hepatitis research group. During this internship at Vall d'Hebron, I wrote my TFM named as "SARS-CoV-2: study of solubility of spike truncated protein (S1) and ongoing viral adaptation in new emerging variants". Furthermore, I worked as an active participant in several competitive projects related to the genomic study of Hepatitis C Virus (HCV) and SARS-CoV-2 variability.


Currently I keep working at the VHIR as PhD student of the Biochemistry, Molecular Biology and Biomedicine PhD Program from the UAB at the Liver Diseases - Viral Hepatitis research group. My PhD thesis is focused on the study of expression, localization and solubility in cell culture of the spike truncated protein of SARS-CoV-2 formed merely by the subunit 1. In addition to the in vitro research, I also study the variability of S gen in different SARS-CoV-2 variants and the adaptation trough human population following the depp-sequencing methodology, thanks to Next Generation Sequencing (NGS) techniques.

Projects

Beca VHIR PhD

IP: Quer Sivila, Josep
Collaborators: Rodrigo Bosch, Sira, Perez Lasarte, Laia, Campos Martinez, Carolina
Funding agency: Fundació Institut de Recerca HUVH
Funding: 69188.74
Reference: VPHD/CAROLINA_C
Duration: 01/04/2023 - 31/03/2026

Estudio de quasispecies por metagenómica en neuropatías asociadas a virus por secuenciación masiva de nueva generación.

IP: Quer Sivila, Josep
Collaborators: Colomer Castell, Sergi, Estudio de quasispecies por metagenómica en neuropatías asociadas a virus por secuenciación masiva de nueva generación., Viladomiu Catà, Lluís, Garcia Cehic, Damir, Piñana Moro, Maria, Pablo Gabriel Medina, Llauradó Gayete, Arnau, Campos Martinez, Carolina, Gonzalez Sánchez, Alejandra
Funding agency: Instituto de Salud Carlos III
Funding: 292820
Reference: PI22/00258
Duration: 01/01/2023 - 31/12/2025

Malalties hepàtiques

IP: Genescà Ferrer, Joan
Collaborators: Minguez Rosique, Beatriz, Colomer Castell, Sergi, Vargas Accarino, Elena, Raurell Saborit, Immaculada, Viladomiu Catà, Lluís, Castells Fusté, Lluis, Riveiro Barciela, Maria del Mar, Vargas Blasco, Victor Manuel, Buti Ferret, Maria, Gomez Perez, Montserrat, Torrens Buscató, Maria Margarita, Vico Romero, Judit, Quer Sivila, Josep, Malalties hepàtiques, Palom Agusti, Adriana, Pericàs Pulido, Juan Manuel, Martell Pérez-Alcalde, Maria Nieves, Garcia Cehic, Damir, Puente Ramo, Laura, Campos Varela, Isabel, Bermúdez Ramos, María, Esteban Mur, Juan Ignacio, Palacio Gutierrez, Ester, Anton Calvo, Susana, Higuera Urbano, Monica, de Sena Fernández, Elena, Ventura Cots, Meritxell, Malalties hepàtiques, Malalties hepàtiques, Bigas Alsina, Emma, Malalties hepàtiques, Campos Martinez, Carolina, Simon-Talero Horga, Macarena, Jesus Manuel Rivera Esteban, Tabernero Caellas, David, Pons Delgado, Mònica, Salzano , Marcella, Cesar Jimenez Hernandez, Malalties hepàtiques, Malalties hepàtiques
Funding agency: AGAUR no fer servir-correcte 4301-37
Funding: 60000
Reference: 2021 SGR 00462
Duration: 01/01/2022 - 31/12/2024

Related news

The research team used nanotechnology to deliver the drug directly to liver cells, which eliminated side effects without reducing effectiveness.

The book is the culmination of the last ten years of research by Dr Gregori, Dr Quer and Dr Rodríguez-Frías in the Viral Hepatitis laboratory

This new method improves and streamlines drug development processes

Related professionals

César Llorente Parrado

César Llorente Parrado

Research technician
Read more
Antía Ferreiro Posse

Antía Ferreiro Posse

Predoctoral researcher
Pneumology
Read more
Elia Rojas Montserrat

Elia Rojas Montserrat

Administration and Management
Diabetes and Metabolism
Read more
Natalia Llonga Tejedor

Natalia Llonga Tejedor

Predoctoral researcher
Psychiatry, Mental Health and Addictions
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.